Search for: "Eli, Inc."
Results 341 - 360
of 1,001
Sorted by Relevance
|
Sort by Date
7 Nov 2014, 5:52 am
Eli Lilly & Co., 394 F. [read post]
6 Oct 2017, 2:34 pm
Gen-Probe Inc., 323 F.3d 956 (Fed. [read post]
6 Oct 2017, 2:34 pm
Gen-Probe Inc., 323 F.3d 956 (Fed. [read post]
9 Mar 2016, 11:43 am
Cir.2010) (quoting Eli Lilly & Co. v. [read post]
15 Apr 2009, 9:58 am
., Inc. [read post]
9 Feb 2015, 5:41 pm
Takeda Pharmaceuticals America Inc., et al, case number CGC-12-518535). [read post]
15 Jul 2010, 2:39 pm
Wyeth, Inc., 613 F. [read post]
18 Aug 2010, 12:19 am
Eon Labs, Inc. [read post]
18 Jun 2020, 2:24 pm
., Inc., Eli Lilly and Company, and Amgen Inc., were joined by the Association of National Advertisers, Inc. in challenging the rule in June 2019. [read post]
17 Jan 2007, 5:24 am
The companies that have been sued to date are Amgen, Inc.; Astrazeneca Pharmaceuticals, L.P.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime requirements. [read post]
22 Jul 2015, 12:40 pm
Indianapolis, Indiana - An Indiana patent attorney for Eli Lilly and Company of Indianapolis, Indiana sued in the Southern District of Indiana alleging that Mylan Laboratories Limited of Hyderabad, India; Mylan Pharmaceuticals Inc. of Morgantown, West Virginia; and Mylan Inc. of Canonsburg, Pennsylvania (collectively, "Mylan") infringed Patent No. 7,772,209 ("the 209 patent"), which covers the pharmaceutical product Alimta®. [read post]
1 Apr 2011, 12:42 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
2 Nov 2011, 11:56 pm
Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) [see judgment, press summary, BAILII] In holding that gene sequences can have industrial application, reversing the lower courts’ findings, the Supreme Court gave primacy two policy arguments- attracting biosciences investment into the UK and bringing UK interpretations in compliance with the European Patent Convention. [read post]
Disclosure of gene from one bacterial source cannot support claims to gene from any bacterial source
22 Sep 2008, 2:46 pm
Hoffmann-La Roche, Inc. after the jump. [read post]
9 Feb 2010, 3:52 am
Court of Appeal (Criminal Division) Curtis v R [2010] EWCA Crim 123 (09 February 2010) Court of Appeal (Civil Division) O’Beirne v Hudson [2010] EWCA Civ 52 (09 February 2010) Drew v Whitbread [2010] EWCA Civ 53 (09 February 2010) B, R (on the application of) v Cornwall Council & Anor [2010] EWCA Civ 55 (09 February 2010) W (Children), Re [2010] EWCA Civ 57 (09 February 2010) Eli Lilly & Co v Human Genome Sciences Inc [2010] EWCA Civ 33 (09 February 2010) D… [read post]
21 Apr 2008, 3:28 am
California Department of Health Services, 07-956, and it relates to 11th Amendment sovereign immunity in patent cases, a topic previously covered in Florida Prepaid Postsecondary, a case which declared part of the patent act unconstitutional.The AP reported: California has filed 21 patent infringement suits since 1990, winning more than $900 million in judgements since 2000, according to the filings, while using sovereign immunity to get suits dismissed at least six times since 1987, including… [read post]
2 Nov 2011, 11:56 pm
Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) [see judgment, press summary, BAILII] In holding that gene sequences can have industrial application, reversing the lower courts’ findings, the Supreme Court gave primacy two policy arguments- attracting biosciences investment into the UK and bringing UK interpretations in compliance with the European Patent Convention. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
19 Oct 2010, 12:20 pm
Eli Lilly & Co., 2010 WL 4024922 (D.S.D. [read post]
24 Jun 2011, 11:19 pm
(FDA Law Blog) Europe seizure of generic drugs: Lilly settles with Indian generics / Eli Lilly???????????? [read post]
